✦ LIBER ✦

Outcomes of ovarian cancer patients after bevacizumab and chemotherapy in primary vs. recurrent setting – A multi-institutional study

✍ Scribed by J. Chan; A. Alvarez-Secord; T. Tillmanns; K. Moore; K. Bevis; A. ElNaggar; L. Perry; C. McClung; C. Tian; W. Huh

Book ID: 113963791
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 63 KB
Volume: 125
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2011.12.236

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The efficacy and safety of chemotherapy

The efficacy and safety of chemotherapy in combination with bevacizumab vs. bevacizumab alone in recurrent epithelial ovarian cancer – A multi-institutional study

✍ K. Fuh; A. Alvarez-Secord; W. Huh; T. Tillmanns; K. Moore; K. Bevis; A. ElNaggar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Factors predictive of toxicity associate

Factors predictive of toxicity associated with bevacizumab and chemotherapy in recurrent ovarian cancer: A multi-institutional study

✍ J. Chan; W. Huh; C. McClung; A. Alvarez-Secord; K. Moore; R. Previs; L. Perry; K 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Prognostic factors predictive of respons

Prognostic factors predictive of response to bevacizumab combined with chemotherapy in recurrent ovarian cancer – A multi-institutional study

✍ A. Alvarez-Secord; W. Huh; T. Tillmanns; K. Moore; J. Chapman; C. McClung; T. Ki 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Feasibility and perioperative outcomes o

Feasibility and perioperative outcomes of robotic-assisted surgery in the management of recurrent ovarian cancer: A multi-institutional study

✍ Escobar, Pedro F.; Levinson, Kimberly L.; Magrina, Javier; Martino, Martin A.; B 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Determining surrogate endpoints predicti

Determining surrogate endpoints predictive of overall survival in patients treated with bevacizumab for advanced ovarian cancer — A multi-institutional study

✍ S. Ueda; A. Alvarez-Secord; W. Huh; T. Tillmanns; K. Moore; R. Previs; L. Perry; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Efficacy of Chemotherapy in BRCA1/2 Muta

Efficacy of Chemotherapy in BRCA1/2 Mutation Carrier Ovarian Cancer in the Setting of PARP Inhibitor Resistance: A Multi-Institutional Study

✍ Ang, Joo Ern (author);Gourley, Charlie (author);Powell, C. Bethan (author);High, 📂 Article 📅 2013 🏛 American Association for Cancer Research 🌐 English ⚖ 230 KB